ArticleTherapeutic advances in neurological disorders2016

One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot study.

Thomas Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.